2015
Clostridium perfringens enterotoxin C‐terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy‐resistant ovarian cancer
Cocco E, Shapiro EM, Gasparrini S, Lopez S, Schwab CL, Bellone S, Bortolomai I, Sumi NJ, Bonazzoli E, Nicoletti R, Deng Y, Saltzman WM, Zeiss CJ, Centritto F, Black JD, Silasi DA, Ratner E, Azodi M, Rutherford TJ, Schwartz PE, Pecorelli S, Santin AD. Clostridium perfringens enterotoxin C‐terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy‐resistant ovarian cancer. International Journal Of Cancer 2015, 137: 2618-2629. PMID: 26060989, PMCID: PMC4573336, DOI: 10.1002/ijc.29632.Peer-Reviewed Original ResearchConceptsPatient-derived xenograftsTumor fluorescenceChemotherapy-resistant ovarian cancerClaudin-3Human ovarian cancer xenograftsTime of surgeryOvarian cancer patientsNeoadjuvant chemotherapy treatmentOvarian cancer xenograftsHealthy organsVivo visualizationTime of intervalBackground fluorescence ratioClostridium perfringens enterotoxinChemotherapy-naïveMicrometastatic diseaseMalignant ascitesOvarian diseaseResidual diseaseOvarian tumorsCancer patientsCancer xenograftsChemotherapy treatmentIP injectionOvarian cancer
2011
Poliomyelitis in MuLV-infected ICR-SCID mice after injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus.
Carlson Scholz JA, Garg R, Compton SR, Allore HG, Zeiss CJ, Uchio EM. Poliomyelitis in MuLV-infected ICR-SCID mice after injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus. Comparative Medicine 2011, 61: 404-11. PMID: 22330347, PMCID: PMC3193062.Peer-Reviewed Original ResearchConceptsAge-dependent poliomyelitisClinical signsDehydrogenase-elevating virusICR-SCID miceSpinal cordRT-PCRMurine leukemia virusLife-long viremiaLactate dehydrogenase-elevating virusLeukemia virusVentral spinal cordEndogenous murine leukemia virusPCR-positive animalsLDV infectionClinical presentationAxonal degenerationICR miceVentral rootsTypical neuropathologyTransplantable tumorsInadvertent exposurePoliomyelitisBasement membrane matrixHindlimb musculaturePremonitory signs
2005
Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis
Toy EP, Bonafé N, Savlu A, Zeiss C, Zheng W, Flick M, Chambers SK. Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis. Clinical & Experimental Metastasis 2005, 22: 1-9. PMID: 16132573, DOI: 10.1007/s10585-005-0718-4.Peer-Reviewed Original ResearchConceptsBALB/cProto-oncogene expressionC-fms proto-oncogene expressionExpression groupAthymic BALB/cHuman breast cancer metastasisIntraperitoneal modelBreast cancer metastasisHuman breast carcinoma cellsBreast carcinoma cellsClinical outcomesClinical evidenceTumor sizeC-fmsIntrasplenic injectionPrimary tumorMetastatic spreadOral administrationRU 486SCID miceBreast carcinomaSCID animalsImmunodeficient miceIHC stainingNovel treatments